Werbung
Werbung
CTMX
CytomX Therapeutics, Inc.
4.33
USDGesponsert
+0.08
+1.76%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
4.38
+0.04
+0.92%
CTMX Ergebnisberichte
Positives Überraschungsverhältnis
CTMX übertreffen die 23 der letzten 40Schätzungen.
57%
Nächster Bericht
Datum des nächsten Berichts
04. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$8.30M
/-$0.06
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+39.20%
/-33.33%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-78.21%
/-126.09%
CytomX Therapeutics, Inc. earnings per share and revenue
On 06. Nov. 2025, CTMX reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.05 USD, resulting in a -74.42% surprise. Revenue reached 5.96 million, compared to an expected 11.86 million, with a -49.71% difference. The market reacted with a -13.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 8.30 million USD, implying an decrease of -33.33% EPS, and increase of 39.20% in Revenue from the last quarter.
FAQ
What were CytomX Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CytomX Therapeutics, Inc. reported EPS of -$0.09, missing estimates by -74.42%, and revenue of $5.96M, -49.71% below expectations.
How did the market react to CytomX Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -13.6%, changed from $4.19 before the earnings release to $3.62 the day after.
When is CytomX Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 04. März 2026.
What are the forecasts for CytomX Therapeutics, Inc.'s next earnings report?
Based on 10
analysts, CytomX Therapeutics, Inc. is expected to report EPS of -$0.06 and revenue of $8.30M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung